Arlinda Lee
Stock Analyst at Canaccord Genuity
(1.33)
# 3,662
Out of 5,120 analysts
41
Total ratings
36.59%
Success rate
-0.24%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Arlinda Lee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DCTH Delcath Systems | Maintains: Buy | $18 → $21 | $9.98 | +110.42% | 3 | Sep 7, 2023 | |
| XFOR X4 Pharmaceuticals | Maintains: Buy | $600 → $300 | $3.98 | +7,437.69% | 3 | Apr 5, 2022 | |
| NKTR Nektar Therapeutics | Maintains: Buy | $375 → $90 | $38.12 | +136.10% | 5 | Mar 16, 2022 | |
| RYTM Rhythm Pharmaceuticals | Maintains: Buy | $45 → $36 | $108.99 | -66.97% | 3 | Mar 7, 2022 | |
| CELC Celcuity | Initiates: Buy | $50 | $111.34 | -55.09% | 1 | Oct 8, 2021 | |
| CRSP CRISPR Therapeutics AG | Maintains: Buy | $151 → $160 | $51.31 | +211.83% | 3 | Aug 16, 2021 | |
| BCYC Bicycle Therapeutics | Maintains: Buy | $36 → $40 | $6.49 | +516.33% | 3 | Jul 15, 2021 | |
| RARE Ultragenyx Pharmaceutical | Maintains: Buy | $92 → $105 | $24.76 | +324.07% | 12 | Oct 29, 2020 | |
| HALO Halozyme Therapeutics | Maintains: Buy | $23 → $27 | $74.45 | -63.73% | 3 | May 19, 2020 | |
| BDTX Black Diamond Therapeutics | Initiates: Buy | $50 | $2.54 | +1,868.50% | 1 | Feb 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $225 → $270 | $6.31 | +4,178.92% | 3 | Nov 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $300 → $160 | $0.24 | +67,410.55% | 1 | Mar 29, 2018 |
Delcath Systems
Sep 7, 2023
Maintains: Buy
Price Target: $18 → $21
Current: $9.98
Upside: +110.42%
X4 Pharmaceuticals
Apr 5, 2022
Maintains: Buy
Price Target: $600 → $300
Current: $3.98
Upside: +7,437.69%
Nektar Therapeutics
Mar 16, 2022
Maintains: Buy
Price Target: $375 → $90
Current: $38.12
Upside: +136.10%
Rhythm Pharmaceuticals
Mar 7, 2022
Maintains: Buy
Price Target: $45 → $36
Current: $108.99
Upside: -66.97%
Celcuity
Oct 8, 2021
Initiates: Buy
Price Target: $50
Current: $111.34
Upside: -55.09%
CRISPR Therapeutics AG
Aug 16, 2021
Maintains: Buy
Price Target: $151 → $160
Current: $51.31
Upside: +211.83%
Bicycle Therapeutics
Jul 15, 2021
Maintains: Buy
Price Target: $36 → $40
Current: $6.49
Upside: +516.33%
Ultragenyx Pharmaceutical
Oct 29, 2020
Maintains: Buy
Price Target: $92 → $105
Current: $24.76
Upside: +324.07%
Halozyme Therapeutics
May 19, 2020
Maintains: Buy
Price Target: $23 → $27
Current: $74.45
Upside: -63.73%
Black Diamond Therapeutics
Feb 24, 2020
Initiates: Buy
Price Target: $50
Current: $2.54
Upside: +1,868.50%
Nov 5, 2019
Maintains: Buy
Price Target: $225 → $270
Current: $6.31
Upside: +4,178.92%
Mar 29, 2018
Maintains: Buy
Price Target: $300 → $160
Current: $0.24
Upside: +67,410.55%